Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
Pozycja w akcjach #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Cena akcji
$0.69158324
Kapitalizacja rynkowa
$9.84M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-84.15%
Kraj
JP
Handel Delta-Fly Pharma, Inc. (4598)

Kategoria

Historia ceny akcji dla Delta-Fly Pharma, Inc. (4598)
Najwyższa cena zamknięcia: $0.69 dnia 2026-08-01

Najniższa cena zamknięcia: $3.99 dnia 2024-07-01
Historia cen akcji firmy Delta-Fly Pharma, Inc. od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -37.60%
2025 -13.51%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE